ABCB1 and breast carcinoma: Overexpression of ABCB1 has been shown to be associated with drug resistance in a number of different tumour types [44], including ceritinib resistance in non-small cell lung cancer [45], and with poor clinical outcomes, such as response to chemotherapy in breast cancer [46].